Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Rocket Pharmaceuticals (RCKT) operate in?

Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rocket Pharmaceuticals Stock (NASDAQ: RCKT) stock price, news, charts, stock research, profile.

Open	$14.86
Close	$13.98
Volume / Avg.	1.13M / 842.29K
Day Range	$13.80 - $14.90
52 Wk Range	14.65 - 32.53
Market Cap	$1.28B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	27.64%
Days to Cover	19.14

Recent News

Rocket Stock Down More Than 30% in Past Six Months: Here's Why

Shares of Rocket Pharmaceuticals (NASDAQ: RCKT) have plunged 32.9% in the past six months compared with the industry's decline of 3.4%.

Zacks

Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday

Avi Kapoor

FDA Rejects Rocket Pharmaceuticals' Gene Therapy For Rare Immune Disorder, Asks For More Data, Stock Slides

Rocket Pharmaceuticals shares fell after the FDA issued a Complete Response Letter for Kresladi, a gene therapy for severe leukocyte adhesion deficiency-I. The FDA requested additional CMC information.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$14.86
Close	$13.98
Volume / Avg.	1.13M / 842.29K
Day Range	$13.80 - $14.90
52 Wk Range	14.65 - 32.53
Market Cap	$1.28B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	27.64%
Days to Cover	19.14

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Rocket Pharmaceuticals (RCKT) stock?

You can purchase shares of Rocket Pharmaceuticals (NASDAQ:RCKT) through any online brokerage.

View our list of the best stock brokerages

Who are Rocket Pharmaceuticals (RCKT) competitors?

Other companies in Rocket Pharmaceuticals’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB), Cogent Biosciences (NASDAQ:COGT) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for Rocket Pharmaceuticals (RCKT) stock?

Rocket Pharmaceuticals has a consensus price target of $48.41.

What is the current price for Rocket Pharmaceuticals (RCKT)?

The stock price for Rocket Pharmaceuticals (NASDAQ: RCKT) is $13.9999 last updated November 15, 2024 at 5:58 PM EST.

Does Rocket Pharmaceuticals (RCKT) pay a dividend?

There are no upcoming dividends for Rocket Pharmaceuticals.

When is Rocket Pharmaceuticals (NASDAQ:RCKT) reporting earnings?

Rocket Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Rocket Pharmaceuticals (RCKT) going to split?

There is no upcoming split for Rocket Pharmaceuticals.

What sector and industry does Rocket Pharmaceuticals (RCKT) operate in?

Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Rocket Pharmaceuticals

Rocket Pharmaceuticals (RCKT) Forecast